BGT226

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BGT226, covering 2020-12-17 to 2020-12-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer [Phase 1, Phase 2]

See pricing